Cogent Biosciences, Inc. (COGT)
36.23
-0.50
(-1.36%)
USD |
NASDAQ |
Aug 24, 16:00
36.23
0.00 (0.00%)
Pre-Market: 20:00
Cogent Biosciences Total Return Level : 36.23 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 36.23 |
| August 21, 2026 | 36.73 |
| August 20, 2026 | 35.31 |
| August 19, 2026 | 36.85 |
| August 18, 2026 | 37.40 |
| August 17, 2026 | 37.87 |
| August 14, 2026 | 37.93 |
| August 13, 2026 | 37.31 |
| August 12, 2026 | 38.98 |
| August 11, 2026 | 38.70 |
| August 10, 2026 | 41.53 |
| August 07, 2026 | 42.39 |
| August 06, 2026 | 41.80 |
| August 05, 2026 | 42.27 |
| August 04, 2026 | 42.84 |
| August 03, 2026 | 38.86 |
| July 31, 2026 | 38.93 |
| July 30, 2026 | 41.36 |
| July 29, 2026 | 39.57 |
| July 28, 2026 | 40.67 |
| July 27, 2026 | 40.44 |
| July 24, 2026 | 39.76 |
| July 23, 2026 | 40.24 |
| July 22, 2026 | 39.54 |
| July 21, 2026 | 39.64 |
| Date | Value |
|---|---|
| July 20, 2026 | 38.30 |
| July 17, 2026 | 39.08 |
| July 16, 2026 | 37.94 |
| July 15, 2026 | 39.30 |
| July 14, 2026 | 38.51 |
| July 13, 2026 | 37.46 |
| July 10, 2026 | 38.87 |
| July 09, 2026 | 40.51 |
| July 08, 2026 | 39.97 |
| July 07, 2026 | 40.01 |
| July 06, 2026 | 39.44 |
| July 02, 2026 | 38.69 |
| July 01, 2026 | 38.48 |
| June 30, 2026 | 38.70 |
| June 29, 2026 | 38.74 |
| June 26, 2026 | 38.10 |
| June 25, 2026 | 38.01 |
| June 24, 2026 | 37.53 |
| June 23, 2026 | 36.31 |
| June 22, 2026 | 35.84 |
| June 18, 2026 | 34.54 |
| June 17, 2026 | 33.67 |
| June 16, 2026 | 33.07 |
| June 15, 2026 | 33.17 |
| June 12, 2026 | 33.10 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Apogee Therapeutics, Inc. | 134.79 |
| ImmunityBio, Inc. | 7.58 |
| Erasca, Inc. | 17.60 |
| Arrowhead Pharmaceuticals, Inc. | 86.73 |
| Oncolytics Biotech, Inc. | 0.8441 |